Dhibar Deba Prasad, Sahu Kamal Kant, Jain Sanjay, Kumari Savita, Varma Subhash Chander
Department of Internal Medicine, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
J Emerg Med. 2018 Feb;54(2):221-224. doi: 10.1016/j.jemermed.2017.10.035. Epub 2017 Dec 16.
Methemoglobin (MetHb) is an oxidized form of hemoglobin. It is a poor transporter of oxygen and is unable to deliver oxygen to the tissue. Globally, drug & toxin induced methemoglobinemia is more common as compared with the congenital form. Methemoglobinemia caused by paint thinner intoxication is rare. Methylene blue is well established as the first-line therapy for severe methemoglobinemia.
A 25-year old man was brought to the Emergency Department after accidental consumption of paint thinner. On clinical examination, he had cyanosis and there were discrepancies in his pulse oximetry and arterial blood gas (ABG) analysis results. With this clue and supporting laboratory investigations, the diagnosis of toxin-induced methemoglobinemia was made. Due to the unavailability of methylene blue, alternative treatment with high-dose vitamin C was attempted, to which the patient responded. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: The role of vitamin C in the treatment of methemoglobinemia has not been well established, with only a few published case reports. This patient had severe methemoglobinemia, with MetHb of 46.4%, which responded dramatically to vitamin C therapy, with no side effects. This case shows that high-dose vitamin C is safe and has the potential to be an effective alternative for the treatment of severe methemoglobinemia. In the presence of cyanosis, mismatch of pulse-oximetry and ABG-analysis are the key for the physician to suspect methemoglobinemia.
高铁血红蛋白(MetHb)是血红蛋白的一种氧化形式。它是一种较差的氧气转运体,无法将氧气输送到组织。在全球范围内,药物和毒素诱导的高铁血红蛋白血症比先天性形式更为常见。由油漆稀释剂中毒引起的高铁血红蛋白血症很少见。亚甲蓝已被确立为治疗严重高铁血红蛋白血症的一线疗法。
一名25岁男子在意外摄入油漆稀释剂后被送往急诊科。临床检查时,他有发绀,脉搏血氧饱和度测定和动脉血气(ABG)分析结果存在差异。基于这一线索并结合辅助实验室检查,诊断为毒素诱导的高铁血红蛋白血症。由于没有亚甲蓝,尝试用高剂量维生素C进行替代治疗,患者对此有反应。
急诊医生为何应了解此情况?:维生素C在治疗高铁血红蛋白血症中的作用尚未得到充分证实,仅有少数已发表的病例报告。该患者患有严重的高铁血红蛋白血症,高铁血红蛋白水平为46.4%,对维生素C治疗反应显著,且无副作用。该病例表明高剂量维生素C是安全的,并且有可能成为治疗严重高铁血红蛋白血症的有效替代方法。在出现发绀的情况下,脉搏血氧饱和度测定和ABG分析结果不匹配是医生怀疑高铁血红蛋白血症的关键。